| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.70▲ | 4.68▲ | 4.68▲ | 4.55▲ | 4.99▼ |
| MA10 | 4.70▲ | 4.67▲ | 4.62▲ | 4.56▲ | 5.51▼ |
| MA20 | 4.67▲ | 4.60▲ | 4.54▲ | 5.00▼ | 5.75▼ |
| MA50 | 4.67▲ | 4.47▲ | 4.46▲ | 5.58▼ | 5.98▼ |
| MA100 | 4.61▲ | 4.50▲ | 4.93▼ | 5.85▼ | 6.58▼ |
| MA200 | 4.53▲ | 4.98▼ | 5.34▼ | 5.90▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.003▲ | 0.027▲ | 0.001▲ | -0.167▼ |
| RSI | 57.696▲ | 62.948▲ | 61.942▲ | 41.419▼ | 39.273▼ |
| STOCH | 55.492 | 77.785 | 88.069▲ | 40.868 | 16.610▼ |
| WILL %R | -22.727▲ | -9.091▲ | -6.849▲ | -61.389 | -78.396▼ |
| CCI | 79.873 | 129.502▲ | 109.441▲ | -17.848 | -164.660▼ |
|
Tuesday, December 09, 2025 05:00 AM
The ALSTARS Trial is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of COYA 302 in patients with amyotrophic lateral sclerosis (ALS) ...
|
|
Saturday, November 08, 2025 04:01 PM
As of November 9, 2025, the average one-year price target for Coya Therapeutics is $16.54/share. The forecasts range from a low of $14.14 to a high of $21.00. The average price target represents an ...
|
|
Monday, October 27, 2025 01:01 PM
HOUSTON--(BUSINESS WIRE)-- Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/01/26 | 4.73 | 4.815 | 4.5601 | 4.72 | 304,890 |
| 22/01/26 | 4.54 | 4.76 | 4.49 | 4.73 | 212,574 |
| 21/01/26 | 4.48 | 4.6382 | 4.37 | 4.55 | 302,284 |
| 20/01/26 | 4.21 | 4.56 | 4.0117 | 4.48 | 353,786 |
| 16/01/26 | 4.11 | 4.37 | 4.0612 | 4.28 | 385,311 |
| 15/01/26 | 4.63 | 4.73 | 3.9401 | 4.03 | 1,027,172 |
| 14/01/26 | 4.69 | 4.9491 | 4.62 | 4.64 | 279,123 |
| 13/01/26 | 4.75 | 4.85 | 4.45 | 4.62 | 324,536 |
| 12/01/26 | 4.88 | 4.88 | 4.55 | 4.75 | 364,805 |
| 09/01/26 | 5.15 | 5.15 | 4.78 | 4.85 | 576,966 |
|
|
||||
|
|
||||
|
|